J. Wasicak

发表

Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.

D. Donnelly-roberts, Y. Martin, S. Arneric, 1996, Journal of medicinal chemistry.

Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.

S. Arneric, J. Sullivan, D. Garvey, 1994, Journal of medicinal chemistry.

Conformationally constrained amino acids. Synthesis and optical resolution of 3-substituted proline derivatives

W. Arnold, John Y. L. Chung, M. Holladay, 1990 .

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.

S. Arneric, M. Decker, N. Lin, 1998, The Journal of pharmacology and experimental therapeutics.

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.

D. Donnelly-roberts, D. Mckenna, S. Arneric, 1998, The Journal of pharmacology and experimental therapeutics.

Ligands for brain cholinergic channel receptors: synthesis and in vitro characterization of novel isoxazoles and isothiazoles as bioisosteric replacements for the pyridine ring in nicotine.

D. Anderson, D. Garvey, N. Lin, 1994, Journal of medicinal chemistry.

Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors.

D. Anderson, E. Cadman, D. Garvey, 1992, Journal of medicinal chemistry.

Synthesis of chiral α-acetylenic cyclic amines from α-amino acids : applications to differentially constrained oxotremorine analogues as muscarinic agents

John Y. L. Chung, J. Wasicak, 1990 .

Alkylation of tricarbonyl(diene)iron complexes: Model studies for the preparation of protomycinolide IV ☆

W. A. Donaldson, R. Henry, J. Wasicak, 1997 .

Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.

S. Ng, S. Rosenberg, H. Sham, 1999, Journal of medicinal chemistry.

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.

D. Donnelly-roberts, S. Arneric, C. Briggs, 1998, Journal of medicinal chemistry.

Structural aspects of high affinity ligands for the α4β2 neuronal nicotinic receptor

J. Sullivan, M. Dart, M. Meyer, 2000 .

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.

D. Donnelly-roberts, S. Arneric, J. Sullivan, 1998, Bioorganic & Medicinal Chemistry Letters.

Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.

S. Arneric, M. Decker, N. Lin, 1998, European journal of pharmacology.

A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: In Vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand

D. Donnelly-roberts, D. Mckenna, S. Arneric, 1996, Neuropharmacology.

Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework.

S. Arneric, J. Sullivan, D. Garvey, 1999, Bioorganic & medicinal chemistry letters.

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.

J. Sullivan, J. L. Raszkiewicz, J. Brioni, 1994, The Journal of pharmacology and experimental therapeutics.

Characterization of [3H]ABT-418: a novel cholinergic channel ligand.

S. Arneric, D. Anderson, J. L. Raszkiewicz, 1995, The Journal of pharmacology and experimental therapeutics.

Conformationally Constrained Amino Acids. Synthesis and Optical Resolution of 3‐Substituted Proline Derivatives.

W. Arnold, John Y. L. Chung, M. Holladay, 1990 .

A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.

D. Mckenna, S. Arneric, J. Sullivan, 1996, Neuropharmacology.

ABT — 418, a Novel Nicotinic Agonist

A. D. Rodrigues, W. J. Jackson, Y. Martin, 1994 .